ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 63 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,976,017 | -33.9% | 434,455 | 0.0% | 1.23% | -44.4% |
| Q2 2023 | $4,505,298 | +28.2% | 434,455 | 0.0% | 2.21% | +30.5% |
| Q1 2023 | $3,514,741 | -48.6% | 434,455 | 0.0% | 1.69% | -62.6% |
| Q4 2022 | $6,842,666 | -31.5% | 434,455 | -31.5% | 4.52% | -31.9% |
| Q3 2022 | $9,986,000 | +12.7% | 634,455 | 0.0% | 6.63% | +4.9% |
| Q2 2022 | $8,857,000 | -19.0% | 634,455 | 0.0% | 6.32% | +7.0% |
| Q1 2022 | $10,938,000 | +18.6% | 634,455 | 0.0% | 5.90% | +81.4% |
| Q4 2021 | $9,225,000 | -19.2% | 634,455 | 0.0% | 3.25% | +42.9% |
| Q3 2021 | $11,420,000 | +2.5% | 634,455 | 0.0% | 2.28% | +27.6% |
| Q2 2021 | $11,141,000 | -30.3% | 634,455 | 0.0% | 1.78% | -38.0% |
| Q1 2021 | $15,988,000 | +289.5% | 634,455 | 0.0% | 2.88% | +308.2% |
| Q4 2020 | $4,105,000 | +151.7% | 634,455 | 0.0% | 0.70% | +35.3% |
| Q3 2020 | $1,631,000 | +58.7% | 634,455 | 0.0% | 0.52% | +32.9% |
| Q2 2020 | $1,028,000 | +55.8% | 634,455 | 0.0% | 0.39% | +36.1% |
| Q1 2020 | $660,000 | -45.0% | 634,455 | 0.0% | 0.29% | -37.3% |
| Q4 2019 | $1,199,000 | +75.0% | 634,455 | 0.0% | 0.46% | +28.6% |
| Q3 2019 | $685,000 | -50.7% | 634,455 | 0.0% | 0.36% | -39.8% |
| Q2 2019 | $1,389,000 | -63.4% | 634,455 | 0.0% | 0.59% | -79.5% |
| Q1 2019 | $3,800,000 | -19.0% | 634,455 | 0.0% | 2.90% | -41.4% |
| Q4 2018 | $4,689,000 | – | 634,455 | – | 4.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |